Evidence map›Paper›PMID 18172105›Full record

ArticleInvestigative ophthalmology & visual science2008

Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum.

Sherrina N Green, Melissa Sanders, Quincy C Moore, Erin W Norcross, Kathryn S Monds, Armando R Caballero, Larry S McDaniel, Sherrina A Robinson, Chinwendu Onwubiko, Richard J O'Callaghan and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Population structure of ocularMicrobial genomics · 2022
    Article
  3. Article
  4. The Role of Pneumococcal Virulence Factors in Ocular Infectious Diseases.Interdisciplinary perspectives on infectious diseases · 2018
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2010
    Article
  10. Article
  11. Article
  12. Article
  13. Non-antibiotic management of bacterial keratitis.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Sherrina N GreenDepartment of Microbiology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.
Melissa Sanders
Quincy C Moore
Erin W Norcross
Kathryn S Monds
Armando R Caballero
Larry S McDaniel
Sherrina A Robinson
Chinwendu Onwubiko
Richard J O'Callaghan
Mary E Marquart
University of Mississippi Medical Center · US

Funding

Streptococcus pneumoniae ocular pathogenesis and therapyR01EY016195 · NEI · UNIVERSITY OF MISSISSIPPI MED CTR · PI MARQUART, MARY E · 2007 to 2011
$1.5M
Intramural NIH HHSNEI NIH HHS EY 016195NEI NIH HHS R01 EY016195
6 · The paper itself

Abstract

purposeTo determine whether passive immunization with pneumolysin antiserum can reduce corneal damage associated with pneumococcal keratitis.

methodsNew Zealand White rabbits were intrastromally injected with Streptococcus pneumoniae and then passively immunized with control serum, antiserum against heat-inactivated pneumolysin (HI-PLY), or antiserum against cytotoxin-negative pneumolysin (psiPLY). Slit lamp examinations (SLEs) were performed at 24, 36, and 48 hours after infection. An additional four corneas from rabbits passively immunized with antiserum against psiPLY were examined up to 14 days after infection. Colony forming units (CFUs) were quantitated from corneas extracted at 20 and 48 hours after infection. Histopathology of rabbit eyes was performed at 48 hours after infection.

resultsSLE scores at 36 and 48 hours after infection were significantly lower in rabbits passively immunized with HI-PLY antiserum than in control rabbits (P < or = 0.043). SLE scores at 24, 36, and 48 hours after infection were significantly lower in rabbits passively immunized with psiPLY antiserum than in control rabbits (P < or = 0.010). The corneas of passively immunized rabbits that were examined up to 14 days after infection exhibited a sequential decrease in keratitis, with an SLE score average of 2.000 +/- 1.586 at 14 days. CFUs recovered from infected corneas were not significantly different between each experimental group and the respective control group at 20 or 48 hours after infection (P > or = 0.335). Histologic sections showed more corneal edema and polymorphonuclear leukocyte (PMN) infiltration in control rabbits compared with passively immunized rabbits.

conclusionsHI-PLY and psiPLY both elicit antibodies that provide passive protection against S. pneumoniae keratitis.

Indexed as

Immunization, PassiveAnimalsAntibodies, BacterialBacterial ProteinsColony Count, MicrobialCorneaCorneal UlcerDisease Models, AnimalEnzyme-Linked Immunosorbent AssayEye Infections, BacterialPneumococcal InfectionsPneumococcal VaccinesRabbitsStreptococcus pneumoniaeStreptolysinsVaccinationAntibodies, BacterialBacterial ProteinsplY protein, Streptococcus pneumoniaePneumococcal VaccinesStreptolysins

Identifiers

PMID18172105
PMCPMC2633641
OpenAlexW2036243468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.